Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy

International Immunopharmacology

Volumn 25, Issue 1, 2015, Pages 30-42

  Cucak, Helena ^a   Nielsen Fink, Lisbeth ^a   Højgaard Pedersen, Maiken ^a   Rosendahl, Alexander ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Diabetes; Diabetic nephropathy; Drug treatment; Kidney; Macrophages T cells

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; GALECTIN 3; GLYCOPROTEIN P 15095; HEMOGLOBIN A1C; TRANSFORMING GROWTH FACTOR BETA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELL POLARITY; CELL SUBPOPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; LEUKOCYTE; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPOLARIZATION; 129 MOUSE; ANIMAL; B LYMPHOCYTE; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; KIDNEY; METABOLISM; MUTANT MOUSE STRAIN; PHYSIOLOGY; T LYMPHOCYTE;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, CD11C; B-LYMPHOCYTES; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ENALAPRIL; GALECTIN 3; HUMANS; KIDNEY; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MICE; MICE, 129 STRAIN; MICE, MUTANT STRAINS; T-LYMPHOCYTES;

EID: 84921529737     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.01.003     Document Type: Article

References (62)

1. D.K. Packham, T.P. Alves, J.P. Dwyer, R. Atkins, Z.D. de, and M. Cooper Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database Am J Kidney Dis 59 1 Jan. 2012 75 83
2. T.W. Tervaert, A.L. Mooyaart, K. Amann, A.H. Cohen, H.T. Cook, and C.B. Drachenberg Pathologic classification of diabetic nephropathy J Am Soc Nephrol 21 4 Apr. 2010 556 563
3. P. Ruggenenti, P. Cravedi, and G. Remuzzi The RAAS in the pathogenesis and treatment of diabetic nephropathy Nat Rev Nephrol 6 6 Jun. 2010 319 330
4. T. Yamazaki, M. Tanimoto, T. Gohda, I. Ohara, S. Hagiwara, and M. Murakoshi Combination effects of enalapril and losartan on lipid peroxidation in the kidneys of KK-Ay/Ta mice Nephron Exp Nephrol 113 2 2009 e66 e76
5. Y. Wei, J.R. Sowers, S.E. Clark, W. Li, C.M. Ferrario, and C.S. Stump Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase Am J Physiol Endocrinol Metab 294 2 Feb. 2008 E345 E351
6. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat Rev Immunol 11 2 Feb. 2011 98 107
7. A. Festa, and S.M. Haffner Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial Circulation 111 19 May 17 2005 2414 2415
8. W. Zhang, H. Liu, M. Al-Shabrawey, R.W. Caldwell, and R.B. Caldwell Inflammation and diabetic retinal microvascular complications J Cardiovasc Dis Res 2 2 Apr. 2011 96 103
9. J.F. Navarro-Gonzalez, C. Mora-Fernandez, F.M. Muros de, and J. Garcia-Perez Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy Nat Rev Nephrol 7 6 Jun. 2011 327 340
10. E. Galkina, and K. Ley Leukocyte recruitment and vascular injury in diabetic nephropathy J Am Soc Nephrol 17 2 Feb. 2006 368 377
11. D. Nguyen, F. Ping, W. Mu, P. Hill, R.C. Atkins, and S.J. Chadban Macrophage accumulation in human progressive diabetic nephropathy Nephrology (Carlton) 11 3 Jun. 2006 226 231
12. C. Sassy-Prigent, D. Heudes, C. Mandet, M.F. Belair, O. Michel, and B. Perdereau Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats Diabetes 49 3 Mar. 2000 466 475
13. C.E. Alpers, and K.L. Hudkins Mouse models of diabetic nephropathy Curr Opin Nephrol Hypertens 20 3 May 2011 278 284
14. F. Chow, E. Ozols, D.J. Nikolic-Paterson, R.C. Atkins, and G.H. Tesch Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury Kidney Int 65 1 Jan. 2004 116 128
15. V.M. Dalla, M. Mussap, P. Gallina, M. Bruseghin, A.M. Cernigoi, and A. Saller Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes J Am Soc Nephrol 16 Suppl. 1 Mar. 2005 S78 S82
16. M.M. Pillai, B. Hayes, and B. Torok-Storb Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80- and CSF-1R-expressing populations Exp Hematol 37 12 Dec. 2009 1387 1392
17. S. Gordon, and A. Mantovani Diversity and plasticity of mononuclear phagocytes Eur J Immunol 41 9 Sep. 2011 2470 2472
18. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 12 Dec. 2004 677 686
19. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 5 May 28 2010 593 604
20. S. Gordon Alternative activation of macrophages Nat Rev Immunol 3 1 Jan. 2003 23 35
21. S.D. Ricardo, G.H. van, and A.A. Eddy Macrophage diversity in renal injury and repair J Clin Invest 118 11 Nov. 2008 3522 3530
22. H. Cucak, L.G. Grunnet, and A. Rosendahl Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization J Leukoc Biol 95 1 Jan. 2014 149 160
23. G.H. Tesch Macrophages and diabetic nephropathy Semin Nephrol 30 3 May 2010 290 301
24. S. Devaraj, P. Tobias, B.S. Kasinath, R. Ramsamooj, A. Afify, and I. Jialal Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy Arterioscler Thromb Vasc Biol 31 8 Aug. 2011 1796 1804
25. S. Lee, S. Huen, H. Nishio, S. Nishio, H.K. Lee, and B.S. Choi Distinct macrophage phenotypes contribute to kidney injury and repair J Am Soc Nephrol 22 2 Feb. 2011 317 326
26. E.K. Sean, and P. Cockwell Macrophages and progressive tubulointerstitial disease Kidney Int 68 2 Aug. 2005 437 455
27. K. Fujiu, I. Manabe, and R. Nagai Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice J Clin Invest 121 9 Sep. 2011 3425 3441
28. F.T. Liu, D.K. Hsu, R.I. Zuberi, I. Kuwabara, E.Y. Chi, and W.R. Henderson Jr. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages Am J Pathol 147 4 Oct. 1995 1016 1028
29. G.A. Rabinovich, and M.A. Toscano Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation Nat Rev Immunol 9 5 May 2009 338 352
30. K. Sharma, P. McCue, and S.R. Dunn Diabetic kidney disease in the db/db mouse Am J Physiol Renal Physiol 284 6 Jun. 2003 F1138 F1144
31. A.C. MacKinnon, S.L. Farnworth, P.S. Hodkinson, N.C. Henderson, K.M. Atkinson, and H. Leffler Regulation of alternative macrophage activation by galectin-3 J Immunol 180 4 Feb. 15 2008 2650 2658
32. N.C. Henderson, A.C. MacKinnon, S.L. Farnworth, F. Poirier, F.P. Russo, and J.P. Iredale Galectin-3 regulates myofibroblast activation and hepatic fibrosis Proc Natl Acad Sci U S A 103 13 Mar. 28 2006 5060 5065
33. N.C. Henderson, A.C. MacKinnon, S.L. Farnworth, T. Kipari, C. Haslett, and J.P. Iredale Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis Am J Pathol 172 2 Feb. 2008 288 298
34. K. Garber Galecto Biotech Nat Biotechnol 31 6 Jun. 2013 481
35. F.N. Ziyadeh Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator J Am Soc Nephrol 15 Suppl. 1 Jan. 2004 S55 S57
36. A.C. MacKinnon, M.A. Gibbons, S.L. Farnworth, H. Leffler, U.J. Nilsson, and T. Delaine Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3 Am J Respir Crit Care Med 185 5 Mar. 1 2012 537 546
37. J.J. Bending, A. Lobo-Yeo, D. Vergani, and G.C. Viberti Proteinuria and activated T-lymphocytes in diabetic nephropathy Diabetes 37 5 May 1988 507 511
38. R. Moriya, J.C. Manivel, and M. Mauer Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients Diabetologia 47 1 Jan. 2004 82 88
39. G.G. Vaday, S. Franitza, H. Schor, I. Hecht, A. Brill, and L. Cahalon Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix J Leukoc Biol 69 6 Jun. 2001 885 892
40. J.M. Forbes, and M.E. Cooper Mechanisms of diabetic complications Physiol Rev 93 1 Jan. 2013 137 188
41. F.Y. Chow, D.J. Nikolic-Paterson, R.C. Atkins, and G.H. Tesch Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis Nephrol Dial Transplant 19 12 Dec. 2004 2987 2996
42. T. Furuta, T. Saito, T. Ootaka, J. Soma, K. Obara, and K. Abe The role of macrophages in diabetic glomerulosclerosis Am J Kidney Dis 21 5 May. 1993 480 485
43. D.A. Hume Macrophages as APC and the dendritic cell myth J Immunol 181 9 Nov. 1 2008 5829 5835
44. Y. Ji, S. Sun, S. Xia, L. Yang, X. Li, and L. Qi Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4 J Biol Chem 287 29 Jul. 13 2012 24378 24386
45. D.L. Coleman Diabetes-obesity syndromes in mice Diabetes 31 Suppl. 1 Pt 2 1982 1 6
46. J.Y. Huh, J.I. Kim, Y.J. Park, I.J. Hwang, Y.S. Lee, and J.H. Sohn A novel function of adipocytes in lipid antigen presentation to iNKT cells Mol Cell Biol 33 2 Jan. 2013 328 339
47. A.B. Frey, and T.D. Rao NKT cell cytokine imbalance in murine diabetes mellitus Autoimmunity 29 3 1999 201 214
48. T. Saksida, I. Nikolic, M. Vujicic, U.J. Nilsson, H. Leffler, and M.L. Lukic Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro J Cell Physiol 228 7 Jul. 2013 1568 1576
49. N.N. Pejnovic, J.M. Pantic, I.P. Jovanovic, G.D. Radosavljevic, M.Z. Milovanovic, and I.G. Nikolic Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets Diabetes 62 6 Jun. 2013 1932 1944
50. G. Pugliese, F. Pricci, C. Iacobini, G. Leto, L. Amadio, and P. Barsotti Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice FASEB J 15 13 Nov. 2001 2471 2479
51. Z. Qi, H. Fujita, J. Jin, L.S. Davis, Y. Wang, and A.B. Fogo Characterization of susceptibility of inbred mouse strains to diabetic nephropathy Diabetes 54 9 Sep. 2005 2628 2637
52. C. Iacobini, L. Amadio, G. Oddi, C. Ricci, P. Barsotti, and S. Missori Role of galectin-3 in diabetic nephropathy J Am Soc Nephrol 14 8 Suppl. 3 2003 Aug S264 S270
53. M.C. Carlsson, P. Bengtson, H. Cucak, and H. Leffler Galectin-3 guides intracellular trafficking of some human serotransferrin glycoforms J Biol Chem 288 39 Sep. 27 2013 28398 28408
54. S. Swaminathan, V.A. Fonseca, M.G. Alam, and S.V. Shah The role of iron in diabetes and its complications Diabetes Care 30 7 Jul. 2007 1926 1933
55. K. Shibuya, K. Kanasaki, M. Isono, H. Sato, M. Omata, and T. Sugimoto N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice Diabetes 54 3 Mar. 2005 838 845
56. B. Amann, R. Tinzmann, and B. Angelkort ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1 Diabetes Care 26 8 Aug. 2003 2421 2425
57. L.L. Wu, N. Yang, C.J. Roe, M.E. Cooper, R.E. Gilbert, and R.C. Atkins Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II Kidney Int Suppl 63 Dec. 1997 S221 S225
58. D. Albuquerque, J. Nihei, F. Cardillo, and R. Singh The ACE inhibitors enalapril and captopril modulate cytokine responses in Balb/c and C57Bl/6 normal mice and increase CD4(+)CD103(+)CD25(negative) splenic T cell numbers Cell Immunol 260 2 2010 92 97
59. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 3 Mar. 1 2012 787 795
60. K. Kohlstedt, C. Trouvain, D. Namgaladze, and I. Fleming Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype Basic Res Cardiol 106 2 Mar. 2011 205 215
61. H. Ito, X. Yan, N. Nagata, K. Aritake, Y. Katsumata, and T. Matsuhashi PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis J Am Soc Nephrol 23 11 Nov. 2012 1797 1809
62. M. Platten, S. Youssef, E.M. Hur, P.P. Ho, M.H. Han, and T.V. Lanz Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity Proc Natl Acad Sci U S A 106 35 Sep. 1 2009 14948 14953